Thematic review series: High density lipoprotein structure, function, and metabolism cardioprotective functions of HDLs 1

Journal of Lipid Research

Volumn 55, Issue 2, 2014, Pages 168-179

  Rye, Kerry Anne ^a   Barter, Philip J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Angiogenesis; Apoptosis; Cholesterol effl ux; Endothelial function; Endothelial repair; Oxidation; Pancreatic beta cell function; Thrombosis; Vascular infl ammation

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ANGIOGENESIS; ANIMAL; APOPTOSIS; BLOOD; CARDIOVASCULAR DISEASE; CHOLESTEROL EFFLUX; ENDOTHELIAL FUNCTION; ENDOTHELIAL REPAIR; HUMAN; METABOLISM; OXIDATION; PANCREATIC BETA CELL FUNCTION; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK; THROMBOSIS; VASCULITIS;

ANGIOGENESIS; APOPTOSIS; CHOLESTEROL EFFLUX; ENDOTHELIAL FUNCTION; ENDOTHELIAL REPAIR; OXIDATION; PANCREATIC BETA CELL FUNCTION; THROMBOSIS; VASCULAR INFLAMMATION;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; LIPOPROTEINS, HDL; RISK;

EID: 84893353712     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R039297     Document Type: Review

References (126)

1. Gordon, D. J., J. Knoke, J. L. Probstfield, R. Superko, and H. A. Tyroler.1986.High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Circulation.74 : 1217-1225.
2. Miller, N. E., D. S. Thelle, O. H. Forde, and O. D. Mjos.1977.The Tromso heart-study. High-density lipoprotein and coronary heartdisease: a prospective case-control study. Lancet.1 : 965-968.
3. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber.1977.High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62 : 707-714.
4. Miller, M., A. Seidler, P. O. Kwiterovich, and T. A. Pearson.1992.Long- term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol. Circulation.86 : 1165-1170.
5. Di Angelantonio, E., N. Sarwar, P. Perry, S. Kaptoge, K. K. Ray, A. Thompson, A. M. Wood, S. Lewington, N. Sattar, C. J. Packard, et al.2009.Major lipids, apolipoproteins, and risk of vascular disease. JAMA.302 : 1993-2000.
6. Barter, P., A. M. Gotto, J. C. LaRosa, J. Maroni, M. Szarek, S. M. Grundy, J. J. Kastelein, V. Bittner, and J. C. Fruchart.2007.HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N. Engl. J. Med. 357 : 1301-1310.
7. Rye, K. A., C. A. Bursill, G. Lambert, F. Tabet, and P. J. Barter.2009.The metabolism and anti-Atherogenic properties of HDL. J. Lipid Res. 50 (Suppl.) : S195-S200.
8. Barter, P. J., S. Nicholls, K. A. Rye, G. M. Anantharamaiah, M. Navab, and A. M. Fogelman.2004.Antiinflammatory properties of HDL. Circ. Res. 95 : 764-772.
9. Badimon, J. J., L. Badimon, and V. Fuster.1990.Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J. Clin. Invest. 85 : 1234-1241.
10. Rubin, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift.1991.Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature.353 : 265-267.
11. Duverger, N., H. Kruth, F. Emmanuel, J. M. Caillaud, C. Viglietta, G. Castro, A. Tailleux, C. Fievet, J. C. Fruchart, L. M. Houdebine, et al.1996.Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation.94 : 713-717.
12. Nicholls, S. J., B. Cutri, S. G. Worthley, P. Kee, K. A. Rye, S. Bao, and P. J. Barter.2005.Impact of short-term administration of highdensity lipoproteins and atorvastatin on atherosclerosis in rabbits. Arterioscler. Thromb. Vasc. Biol. 25 : 2416-2421.
13. Nissen, S. E., T. Tsunoda, E. M. Tuzcu, P. Schoenhagen, C. J. Cooper, M. Yasin, G. M. Eaton, M. A. Lauer, W. S. Sheldon, C. L. Grines, et al.2003.Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA.290 : 2292-2300.
14. Tardif, J. C., J. Gregoire, P. L. L'Allier, R. Ibrahim, J. Lesperance, T. M. Heinonen, S. Kouz, C. Berry, R. Basser, M. A. Lavoie, et al.2007.Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA.297 : 1675-1682.
15. Barter, P. J., M. Caulfield, M. Eriksson, S. M. Grundy, J. J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J. C. Tardif, D. D. Waters, et al.2007.Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357 : 2109-2122.
16. Boden, W. E., J. L. Probstfield, T. Anderson, B. R. Chaitman, P. Desvignes-Nickens, K. Koprowicz, R. McBride, K. Teo, and W. Weintraub.2011. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365 : 2255-2267.
17. Schwartz, G. G., A. G. Olsson, M. Abt, C. M. Ballantyne, P. J. Barter, J. Brumm, B. R. Chaitman, I. M. Holme, D. Kallend, L. A. Leiter, et al.2012.Effects of dalcetrapib in patients with a recent acute coronary syndrome. N. Engl. J. Med. 367 : 2089-2099.
18. Voight, B. F., G. M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, M. K. Jensen, G. Hindy, H. Holm, E. L. Ding, T. Johnson, et al.2012.Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet.380 : 572-580.
19. van der Steeg, W. A., I. Holme, S. M. Boekholdt, M. L. Larsen, C. Lindahl, E. S. Stroes, M. J. Tikkanen, N. J. Wareham, O. Faergeman, A. G. Olsson, et al.2008.High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. J. Am. Coll. Cardiol. 51 : 634-642.
20. Poynten, A. M., S. K. Gan, A. D. Kriketos, A. O'Sullivan, J. J. Kelly, B. A. Ellis, D. J. Chisholm, and L. V. Campbell.2003.Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content. Metabolism.52 : 699-704.
21. Ridker, P. M., J. Genest, S. M. Boekholdt, P. Libby, A. M. Gotto, B. G. Nordestgaard, S. Mora, J. G. MacFadyen, R. J. Glynn, and J. J. Kastelein.2010.HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet.376 : 333-339.
22. Besler, C., K. Heinrich, L. Rohrer, C. Doerries, M. Riwanto, D. M. Shih, A. Chroni, K. Yonekawa, S. Stein, N. Schaefer, et al.2011.Mechanisms underlying adverse effects of HDL on eNOS-Activating pathways in patients with coronary artery disease. J. Clin. Invest. 121 : 2693-2708.
23. Duffy, D., and D. J. Rader.2006.Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport. Circulation.113 : 1140-1150.
24. Cockerill, G. W., K. A. Rye, J. R. Gamble, M. A. Vadas, and P. J. Barter.1995.High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15 : 1987-1994.
25. Mineo, C., H. Deguchi, J. H. Griffin, and P. W. Shaul.2006.Endothelial and antithrombotic actions of HDL. Circ. Res. 98 : 1352-1364.
26. Bisoendial, R. J., G. K. Hovingh, J. H. Levels, P. G. Lerch, I. Andresen, M. R. Hayden, J. J. Kastelein, and E. S. Stroes.2003.Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation.107 : 2944-2948.
27. Seetharam, D., C. Mineo, A. K. Gormley, L. L. Gibson, W. Vongpatanasin, K. L. Chambliss, L. D. Hahner, M. L. Cummings, R. L. Kitchens, Y. L. Marcel, et al.2006.High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ. Res. 98 : 63-72.
28. Tso, C., G. Martinic, W. H. Fan, C. Rogers, K. A. Rye, and P. J. Barter.2006.High-density lipoproteins enhance progenitormediated endothelium repair in mice. Arterioscler. Thromb. Vasc. Biol. 26 : 1144-1149.
29. Sumi, M., M. Sata, S. Miura, K. A. Rye, N. Toya, Y. Kanaoka, K. Yanaga, T. Ohki, K. Saku, and R. Nagai.2007.Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 27 : 813-818.
30. Yvan-Charvet, L., T. Pagler, E. L. Gautier, S. Avagyan, R. L. Siry, S. Han, C. L. Welch, N. Wang, G. J. Randolph, H. W. Snoeck, et al.2010.ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science.328 : 1689-1693.
31. Drew, B. G., S. J. Duffy, M. F. Formosa, A. K. Natoli, D. C. Henstridge, S. A. Penfold, W. G. Thomas, N. Mukhamedova, B. de Courten, J. M. Forbes, et al.2009.High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation.119 : 2103-2111.
32. Drew, B. G., K. A. Rye, S. J. Duffy, P. Barter, and B. A. Kingwell.2012.The emerging role of HDL in glucose metabolism. Nat. Rev. Endocrinol. 8 : 237-245.
33. Rye, K. A., and P. J. Barter.2004.Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler. Thromb. Vasc. Biol. 24 : 421-428.
34. Rye, K. A., M. A. Clay, and P. J. Barter.1999.Remodelling of high density lipoproteins by plasma factors. Atherosclerosis.145 : 227-238.
35. Blanche, P. J., E. L. Gong, T. M. Forte, and A. V. Nichols.1981. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim. Biophys. Acta.665 : 408-419.
36. Castro, G. R., and C. J. Fielding.1988.Early incorporation of cellderived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry.27 : 25-29.
37. Cheung, M. C., and J. J. Albers.1984.Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 259 : 12201-12209.
38. Huang, Y., A. von Eckardstein, S. Wu, N. Maeda, and G. Assmann.994.A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc. Natl. Acad. Sci. USA.91 : 1834-1838.
39. Amouyel, P., D. Isorez, J. M. Bard, M. Goldman, P. Lebel, G. Zylberberg, and J. C. Fruchart.1993.Parental history of early myocardial infarction is associated with decreased levels of lipoparticle AI in adolescents. Arterioscler. Thromb. 13 : 1640-1644.
40. Miller, N. E. 1987.Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am. Heart J. 113 : 589-597.
41. Johansson, J., J. Molgaard, and A. G. Olsson.1991.Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemia. Atherosclerosis.91 : 175-184.
42. Neuman, M. P., H. R. Neuman, and J. Neuman.1991.Significant increase of high-density lipoprotein2-cholesterol under prolonged simvastatin treatment. Atherosclerosis.91 (Suppl.) : S11-S19.
43. Kuvin, J. T., D. M. Dave, K. A. Sliney, P. Mooney, A. R. Patel, C. D. Kimmelstiel, and R. H. Karas.2006.Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease. Am. J. Cardiol. 98 : 743-745.
44. Brousseau, M. E., E. J. Schaefer, M. L. Wolfe, L. T. Bloedon, A. G. Digenio, R. W. Clark, J. P. Mancuso, and D. J. Rader.2004.Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N. Engl. J. Med. 350 : 1505-1515.
45. Bard, J. M., H. J. Parra, R. Camare, G. Luc, O. Ziegler, C. Dachet, E. Bruckert, P. Douste-Blazy, P. Drouin, B. Jacotot, et al.1992.A multicenter comparison of the effects of simvastatin and fenofi-brate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition. Metabolism.41 : 498-503.
46. Plump, A. S., C. J. Scott, and J. L. Breslow.1994.Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA.91 : 9607-9611.
47. Chiesa, G., E. Monteggia, M. Marchesi, P. Lorenzon, M. Laucello, V. Lorusso, C. Di Mario, E. Karvouni, R. S. Newton, C. L. Bisgaier, et al.2002.Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ. Res. 90 : 974-980.
48. Okamoto, H., F. Yonemori, K. Wakitani, T. Minowa, K. Maeda, and H. Shinkai.2000.A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature.406 : 203-207.
49. Morehouse, L. A., E. D. Sugarman, P. A. Bourassa, T. M. Sand, F. Zimetti, F. Gao, G. H. Rothblat, and A. J. Milici.2007.Inhibition of CETP activity by torcetrapib reduces susceptibility to dietinduced atherosclerosis in New Zealand White rabbits. J. Lipid Res. 48 : 1263-1272.
50. Brousseau, M. E., R. D. Kauffman, E. E. Herderick, S. J. Demosky, Jr. ., W. Evans, S. Marcovina, S. Santamarina-Fojo, H. B. Brewer, Jr. ., and J. M. Hoeg.2000.LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits. Arterioscler. Thromb. Vasc. Biol. 20 : 450-458.
51. Berard, A. M., B. Foger, A. Remaley, R. Shamburek, B. L. Vaisman, G. Talley, B. Paigen, R. F. Hoyt, Jr. ., S. Marcovina, H. B. Brewer, Jr. ., et al.1997.High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nat. Med. 3 : 744-749.
52. Ko, K. W., A. Paul, K. Ma, L. Li, and L. Chan.2005.Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/-And LDLR-/-mice. J. Lipid Res. 46 : 2586-2594.
53. Jessup, W., I. C. Gelissen, K. Gaus, and L. Kritharides.2006.Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr. Opin. Lipidol. 17 : 247-257.
54. Oram, J. F., R. M. Lawn, M. R. Garvin, and D. P. Wade.2000.ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275 : 34508-34511.
55. Santamarina-Fojo, S., K. Peterson, C. Knapper, Y. Qiu, L. Freeman, J. F. Cheng, J. Osorio, A. Remaley, X. P. Yang, C. Haudenschild, et al.2000.Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc. Natl. Acad. Sci. USA.97 : 7987-7992.
56. Wang, N., D. Lan, W. Chen, F. Matsuura, and A. R. Tall.2004.ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA.101 : 9774-9779.
57. Nakamura, K., M. A. Kennedy, A. Baldan, D. D. Bojanic, K. Lyons, and P. A. Edwards.2004.Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J. Biol. Chem. 279 : 45980-45989.
58. Yancey, P. G., A. E. Bortnick, G. Kellner-Weibel, M. de la Llera-Moya, M. C. Phillips, and G. H. Rothblat.2003.Importance of different pathways of cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23 : 712-719.
59. Ji, Y., B. Jian, N. Wang, Y. Sun, M. L. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall.1997.Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272 : 20982-20985.
60. Yokoyama, S. 2006.ABCA1 and biogenesis of HDL. J. Atheroscler. Thromb. 13 : 1-15.
61. Cuchel, M., S. Lund-Katz, M. de la Llera-Moya, J. S. Millar, D. Chang, I. Fuki, G. H. Rothblat, M. C. Phillips, and D. J. Rader.2010.Pathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophages. Arterioscler. Thromb. Vasc. Biol. 30 : 526-532.
62. Adorni, M. P., F. Zimetti, J. T. Billheimer, N. Wang, D. J. Rader, M. C. Phillips, and G. H. Rothblat.2007.The roles of different pathways in the release of cholesterol from macrophages. J. Lipid Res. 48 : 2453-2462.
63. Khera, A. V., M. Cuchel, M. de la Llera-Moya, A. Rodrigues, M. F. Burke, K. Jafri, B. C. French, J. A. Phillips, M. L. Mucksavage, R. L. Wilensky, et al.2011.Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364 : 127-135.
64. Favari, E., L. Calabresi, M. P. Adorni, W. Jessup, S. Simonelli, G. Franceschini, and F. Bernini.2009.Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1. Biochemistry.48 : 11067-11074.
65. Remaley, A. T., J. A. Stonik, S. J. Demosky, E. B. Neufeld, A. V. Bocharov, T. G. Vishnyakova, T. L. Eggerman, A. P. Patterson, N. J. Duverger, S. Santamarina-Fojo, et al.2001.Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280 : 818-823.
66. Sankaranarayanan, S., J. F. Oram, B. F. Asztalos, A. M. Vaughan, S. Lund-Katz, M. P. Adorni, M. C. Phillips, and G. H. Rothblat.2009.Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux. J. Lipid Res. 50 : 275-284.
67. Yancey, P. G., M. de la Llera-Moya, S. Swarnakar, P. Monzo, S. M. Klein, M. A. Connelly, W. J. Johnson, D. L. Williams, and G. H. Rothblat.2000.High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J. Biol. Chem. 275 : 36596-36604.
68. Sankaranarayanan, S., M. de la Llera-Moya, D. Drazul-Schrader, B. F. Asztalos, G. L. Weibel, and G. H. Rothblat.2010.Importance of macrophage cholesterol content on the flux of cholesterol mass. J. Lipid Res. 51 : 3243-3249.
69. Navab, M., S. S. Imes, S. Y. Hama, G. P. Hough, L. A. Ross, R. W. Bork, A. J. Valente, J. A. Berliner, D. C. Drinkwater, H. Laks, et al.1991.Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 88 : 2039-2046.
70. Mackness, M. I., P. N. Durrington, and B. Mackness.2004.The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am. J. Cardiovasc. Drugs.4 : 211-217.
71. Garner, B., P. K. Witting, A. R. Waldeck, J. K. Christison, M. Raftery, and R. Stocker.1998.Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. J. Biol. Chem. 273 : 6080-6087.
72. Wong, W. M., A. B. Gerry, W. Putt, J. L. Roberts, R. B. Weinberg, S. E. Humphries, D. S. Leake, and P. J. Talmud.2007.Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation. Atherosclerosis.192 : 266-274.
73. Ostos, M. A., M. Conconi, L. Vergnes, N. Baroukh, J. Ribalta, J. Girona, J. M. Caillaud, A. Ochoa, and M. M. Zakin.2001.Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21 : 1023-1028.
74. Tarnus, E., H. Wassef, J. F. Carmel, P. Rondeau, M. Roche, J. Davignon, L. Bernier, and E. Bourdon.2009.Apolipoprotein E limits oxidative stress-induced cell dysfunctions in human adipocytes. FEBS Lett. 583 : 2042-2048.
75. Zerrad-Saadi, A., P. Therond, S. Chantepie, M. Couturier, K. A. Rye, M. J. Chapman, and A. Kontush.2009.HDL3-mediated inactivation of LDL-Associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 29 : 2169-2175.
76. Christison, J. K., K. A. Rye, and R. Stocker.1995.Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein. J. Lipid Res. 36 : 2017-2026.
77. Camont, L., M. J. Chapman, and A. Kontush.2011.Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol. Med. 17 : 594-603.
78. Baker, P. W., K. A. Rye, J. R. Gamble, M. A. Vadas, and P. J. Barter.2000.Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. J. Lipid Res. 41 : 1261-1267.
79. Ashby, D. T., K. A. Rye, M. A. Clay, M. A. Vadas, J. R. Gamble, and P. J. Barter.1998.Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18 : 1450-1455.
80. Dimayuga, P., J. Zhu, S. Oguchi, K. Y. Chyu, X. O. Xu, J. Yano, P. K. Shah, J. Nilsson, and B. Cercek.1999.Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice. Biochem. Biophys. Res. Commun. 264 : 465-468.
81. Rong, J. X., J. Li, E. D. Reis, R. P. Choudhury, H. M. Dansky, V. I. Elmalem, J. T. Fallon, J. L. Breslow, and E. A. Fisher.2001.Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation.104 : 2447-2452.
82. Cockerill, G. W., T. Y. Huehns, A. Weerasinghe, C. Stocker, P. G. Lerch, N. E. Miller, and D. O. Haskard.2001.Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation.103 : 108-112.
83. Paterno, R., A. Ruocco, A. Postiglione, A. Hubsch, I. Andresen, and M. G. Lang.2004.Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke. Cerebrovasc. Dis. 17 : 204-211.
84. Nicholls, S. J., G. J. Dusting, B. Cutri, S. Bao, G. R. Drummond, K. A. Rye, and P. J. Barter.2005.Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation.111 : 1543-1550.
85. Puranik, R., S. Bao, E. Nobecourt, S. J. Nicholls, G. J. Dusting, P. J. Barter, D. S. Celermajer, and K. A. Rye.2008.Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis.196 : 240-247.
86. Clay, M. A., D. H. Pyle, K. A. Rye, M. A. Vadas, J. R. Gamble, and P. J. Barter.2001.Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins. Atherosclerosis.157 : 23-29.
87. McGrath, K. C., X. H. Li, R. Puranik, E. C. Liong, J. T. Tan, V. M. Dy, B. A. DiBartolo, P. J. Barter, K. A. Rye, and A. K. Heather.2009.Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29 : 877-882.
88. Wu, B. J., K. Chen, S. Shrestha, K. L. Ong, P. J. Barter, and K. A. Rye.2013.High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3beta-hydroxysteroid-Delta24 reductase expression and inducing heme oxygenase-1. Circ. Res. 112 : 278-288.
89. Liu, Y., and C. Tang.2012.Regulation of ABCA1 functions by signaling pathways. Biochim. Biophys. Acta.1821 : 522-529.
90. Saddar, S., C. Mineo, and P. W. Shaul.2010.Signaling by the highaffinity HDL receptor scavenger receptor B type I. Arterioscler. Thromb. Vasc. Biol. 30 : 144-150.
91. Whetzel, A. M., J. M. Sturek, M. H. Nagelin, D. T. Bolick, A. K. Gebre, J. S. Parks, A. C. Bruce, M. D. Skaflen, and C. C. Hedrick.2010.ABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions. Arterioscler. Thromb. Vasc. Biol. 30 : 809-817.
92. Baker, P. W., K. A. Rye, J. R. Gamble, M. A. Vadas, and P. J. Barter.999.Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J. Lipid Res. 40 : 345-353.
93. Korporaal, S. J., I. Meurs, A. D. Hauer, R. B. Hildebrand, M. Hoekstra, H. T. Cate, D. Pratico, J. W. Akkerman, T. J. Van Berkel, J. Kuiper, et al.2011.Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol. Arterioscler. Thromb. Vasc. Biol. 31 : 34-42.
94. Ma, Y., M. Z. Ashraf, and E. A. Podrez.2010.Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia. Blood.116 : 1932-1941.
95. Brill, A., A. Yesilaltay, S. F. De Meyer, J. Kisucka, T. A. Fuchs, O. Kocher, M. Krieger, and D. D. Wagner.2012.Extrahepatic highdensity lipoprotein receptor SR-BI and apoA-I protect against deep vein thrombosis in mice. Arterioscler. Thromb. Vasc. Biol. 32 : 1841-1847.
96. Eichinger, S., N. M. Pecheniuk, G. Hron, H. Deguchi, M. Schemper, P. A. Kyrle, and J. H. Griffin.2007.High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation.115 : 1609-1614.
97. Deguchi, H., N. M. Pecheniuk, D. J. Elias, P. M. Averell, and J. H. Griffin.2005.High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation.12 : 893-899.
98. Feng, Y., F. Jacobs, E. Van Craeyveld, C. Brunaud, J. Snoeys, M. Tjwa, S. Van Linthout, and B. De Geest.2008.Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 28 : 278-283.
99. Spieker, L. E., I. Sudano, D. Hurlimann, P. G. Lerch, M. G. Lang, C. Binggeli, R. Corti, F. Ruschitzka, T. F. Luscher, and G. Noll.2002.High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation.105 : 1399-1402.
100. Yuhanna, I. S., Y. Zhu, B. E. Cox, L. D. Hahner, S. Osborne-Lawrence, P. Lu, Y. L. Marcel, R. G. Anderson, M. E. Mendelsohn, H. H. Hobbs, et al.2001.High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat. Med. 7 : 853-857.
101. Sorrentino, S. A., C. Besler, L. Rohrer, M. Meyer, K. Heinrich, F. H. Bahlmann, M. Mueller, T. Horvath, C. Doerries, M. Heinemann, et al.2010.Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation.21 : 110-122.
102. Zhang, Q. H., X. Y. Zu, R. X. Cao, J. H. Liu, Z. C. Mo, Y. Zeng, Y. B. Li, S. L. Xiong, X. Liu, D. F. Liao, et al.2012.An involvement of SR-B1 mediated PI3K-Akt-eNOS signaling in HDL-induced cyclooxygenase 2 expression and prostacyclin production in endothelial cells. Biochem. Biophys. Res. Commun. 420 : 17-23.
103. Zhang, Q., H. Yin, P. Liu, H. Zhang, and M. She.2010.Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway. Exp. Biol. Med. (Maywood).235 : 1082-1092.
104. Huang, C. Y., F. Y. Lin, C. M. Shih, H. K. Au, Y. J. Chang, H. Nakagami, R. Morishita, N. C. Chang, K. G. Shyu, and J. W. Chen.2012.Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-Associated kinase pathways. Arterioscler. Thromb. Vasc. Biol. 32 : 2405-2417.
105. Miura, S., M. Fujino, Y. Matsuo, A. Kawamura, H. Tanigawa, H. Nishikawa, and K. Saku.2003.High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23 : 802-808.
106. Coller, B. S. 2005.Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler. Thromb. Vasc. Biol. 25 : 658-670.
107. Murphy, A. J., M. Akhtari, S. Tolani, T. Pagler, N. Bijl, C. L. Kuo, M. Wang, M. Sanson, S. Abramowicz, C. Welch, et al.2011.ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J. Clin. Invest. 121 : 4138-4149.
108. Barter, P. J., K. A. Rye, J. C. Tardif, D. D. Waters, S. M. Boekholdt, A. Breazna, and J. J. Kastelein.2011.Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Circulation.124 : 555-562.
109. Sazonov, V., D. Maccubbin, C. M. Sisk, and P. L. Canner.2013.Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose. Int. J. Clin. Pract. 67 : 297-302.
110. Fryirs, M. A., P. J. Barter, M. Appavoo, B. E. Tuch, F. Tabet, A. K. Heather, and K. A. Rye.2010.Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler. Thromb. Vasc. Biol. 30 : 1642-1648.
111. Rutti, S., J. A. Ehses, R. A. Sibler, R. Prazak, L. Rohrer, S. Georgopoulos, D. T. Meier, N. Niclauss, T. Berney, M. Y. Donath, et al.2009.Low-And high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology.150 : 4521-4530.
112. Peterson, S. J., D. H. Kim, M. Li, V. Positano, L. Vanella, L. F. Rodella, F. Piccolomini, N. Puri, A. Gastaldelli, C. Kusmic, et al.2009.The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice. J. Lipid Res. 50 : 1293-1304.
113. Dalla-Riva, J., K. G. Stenkula, J. Petrlova, and J. O. Lagerstedt. Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle. J. Lipid Res. 54 : 1275-1282.
114. Weng, W., and J. L. Breslow.1996.Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc. Natl. Acad. Sci. USA.93 : 14788-14794.
115. Ruan, X., Z. Li, Y. Zhang, L. Yang, Y. Pan, Z. Wang, G. S. Feng, and Y. Chen.2011.Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat. J. Cell. Mol. Med. 15 : 763-772.
116. Terasaka, N., N. Wang, L. Yvan-Charvet, and A. R. Tall.2007.High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc. Natl. Acad. Sci. USA.104 : 15093-15098.
117. Suc, I., I. Escargueil-Blanc, M. Troly, R. Salvayre, and A. Negre-Salvayre.1997.HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 17 : 2158-2166.
118. de Souza, J. A., C. Vindis, A. Negre-Salvayre, K. A. Rye, M. Couturier, P. Therond, S. Chantepie, R. Salvayre, M. J. Chapman, and A. Kontush.2010.Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I. J. Cell. Mol. Med. 14 : 608-620.
119. Riwanto, M., L. Rohrer, B. Roschitzki, C. Besler, P. Mocharla, M. Mueller, D. Perisa, K. Heinrich, L. Altwegg, A. von Eckardstein, et al.2013.Altered activation of endothelial anti-And proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation.127 : 891-904.
120. Roehrich, M. E., V. Mooser, V. Lenain, J. Herz, J. Nimpf, S. Azhar, M. Bideau, A. Capponi, P. Nicod, J. A. Haefliger, et al.2003.Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J. Biol. Chem. 278 : 18368-18375.
121. Xia, P., L. Wang, J. R. Gamble, and M. A. Vadas.1999.Activation of sphingosine kinase by tumor necrosis factor-Alpha inhibits apoptosis in human endothelial cells. J. Biol. Chem. 274 : 34499-34505.
122. Kimura, T., K. Sato, E. Malchinkhuu, H. Tomura, K. Tamama, A. Kuwabara, M. Murakami, and F. Okajima.2003.High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler. Thromb. Vasc. Biol. 23 : 1283-1288.
123. Theilmeier, G., C. Schmidt, J. Herrmann, P. Keul, M. Schafers, I. Herrgott, J. Mersmann, J. Larmann, S. Hermann, J. Stypmann, et al.2006.High-density lipoproteins and their constituent, sphingosine-1- phosphate, directly protect the heart against ischemia/ reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation.114 : 1403-1409.
124. Kontush, A., P. Therond, A. Zerrad, M. Couturier, A. Negre-Salvayre, J. A. de Souza, S. Chantepie, and M. J. Chapman.2007.Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities. Arterioscler. Thromb. Vasc. Biol. 27 : 1843-1849.
125. Nofer, J. R., B. Levkau, I. Wolinska, R. Junker, M. Fobker, A. von Eckardstein, U. Seedorf, and G. Assmann.2001.Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-Associated lysosphingolipids. J. Biol. Chem. 276 : 34480-34485.
126. Riwanto, M., and U. Landmesser.2013.High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease. J. Lipid Res. 54 : 3227-3243.